240 related articles for article (PubMed ID: 28803087)
1. Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Kilgore K; Frisbee-Hume S; Park M; Liu D; Balachandran DD; Bruera E
J Pain Symptom Manage; 2017 Dec; 54(6):798-805. PubMed ID: 28803087
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
Hui D; Kilgore K; Park M; Williams J; Liu D; Bruera E
J Pain Symptom Manage; 2016 Oct; 52(4):459-468.e1. PubMed ID: 27401508
[TBL] [Abstract][Full Text] [Related]
3. Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial.
Hui D; Xu A; Frisbee-Hume S; Chisholm G; Morgado M; Reddy S; Bruera E
J Pain Symptom Manage; 2014 Feb; 47(2):209-17. PubMed ID: 23830530
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Hernandez F; Larsson L; Liu D; Kilgore K; Naberhuis J; Virgilio A; Reddy S; Reddy A; Dalal S; Haider A; Driver L; Azhar A; Dev R; Bruera E
J Pain Symptom Manage; 2019 Oct; 58(4):605-613. PubMed ID: 31276809
[TBL] [Abstract][Full Text] [Related]
5. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl buccal tablet.
Messina J; Darwish M; Fine PG
Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
[TBL] [Abstract][Full Text] [Related]
7. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
Portenoy RK; Messina J; Xie F; Peppin J
Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
[TBL] [Abstract][Full Text] [Related]
8. EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.
Simon ST; Kloke M; Alt-Epping B; Gärtner J; Hellmich M; Hein R; Piel M; Cornely OA; Nauck F; Voltz R
J Pain Symptom Manage; 2016 Nov; 52(5):617-625. PubMed ID: 27693898
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
Portenoy RK; Taylor D; Messina J; Tremmel L
Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
[TBL] [Abstract][Full Text] [Related]
11. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
Slatkin NE; Xie F; Messina J; Segal TJ
J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
Mercadante S; Ferrera P; Adile C; Casuccio A
J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
[TBL] [Abstract][Full Text] [Related]
13. Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer.
Blick SK; Wagstaff AJ
Drugs; 2006; 66(18):2387-93; discussion 2394-5. PubMed ID: 17181383
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
[TBL] [Abstract][Full Text] [Related]
15. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer.
Pinna MÁ; Bruera E; Moralo MJ; Correas MÁ; Vargas RM
Am J Hosp Palliat Care; 2015 May; 32(3):298-304. PubMed ID: 24259406
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study.
Weinstein SM; Messina J; Xie F
Cancer; 2009 Jun; 115(11):2571-9. PubMed ID: 19373888
[TBL] [Abstract][Full Text] [Related]
17. Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study.
Darwish M; Kirby M; Robertson P; Tracewell W; Xie F
Clin Drug Investig; 2010; 30(6):365-73. PubMed ID: 20441245
[TBL] [Abstract][Full Text] [Related]
18. Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain.
Webster LR; Messina J; Xie F; Nalamachu S
J Opioid Manag; 2011; 7(4):297-308. PubMed ID: 21957829
[TBL] [Abstract][Full Text] [Related]
19. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
20. Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Drug Investig; 2007; 27(9):605-11. PubMed ID: 17705569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
